Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TRV
|
Avrohom J. Kess
Vice Chmn & Chief Legal Off |
SELL
Payment of exercise price or tax liability
|
Direct | 70,079 Reduced 49.39% |
$19,138,574
$273.1 p/Share
|
May 29
2025 |
|
TRV
|
Avrohom J. Kess
Vice Chmn & Chief Legal Off |
BUY
Exercise of conversion of derivative security
|
Direct | 93,513 Added 49.69% |
$11,277,667
$120.6 p/Share
|
May 29
2025 |
|
TRV
|
Avrohom J. Kess
Vice Chmn & Chief Legal Off |
SELL
Open market or private sale
|
Direct | 23,434 Reduced 32.63% |
$6,420,681
$273.99 p/Share
|
May 29
2025 |
|
ACHC
|
Patrice A Harris |
BUY
Grant, award, or other acquisition
|
Direct | 7,032 Added 37.78% |
-
|
May 29
2025 |
|
ACHC
|
Ralph David Kelly |
BUY
Grant, award, or other acquisition
|
Direct | 11,955 Added 37.38% |
-
|
May 29
2025 |
|
ACHC
|
Jason Bernhard |
BUY
Grant, award, or other acquisition
|
Direct | 11,515 Added 25.35% |
-
|
May 29
2025 |
|
ACHC
|
Michael Fucci |
BUY
Grant, award, or other acquisition
|
Direct | 7,032 Added 24.37% |
-
|
May 29
2025 |
|
ACHC
|
William Grieco |
BUY
Grant, award, or other acquisition
|
Direct | 11,427 Added 11.28% |
-
|
May 29
2025 |
|
ACHC
|
Reeve B Waud |
BUY
Grant, award, or other acquisition
|
Direct | 17,669 Added 22.76% |
-
|
May 29
2025 |
|
ACHC
|
Vicky B Gregg |
BUY
Grant, award, or other acquisition
|
Direct | 7,032 Added 16.23% |
-
|
May 29
2025 |
|
ACHC
|
Wade D Miquelon |
BUY
Grant, award, or other acquisition
|
Direct | 7,032 Added 11.24% |
-
|
May 29
2025 |
|
ACHC
|
E. Perot Bissell |
BUY
Grant, award, or other acquisition
|
Direct | 7,032 Added 13.35% |
-
|
May 29
2025 |
|
DCO
|
Stephen G Oswald
Chairman, President & CEO |
SELL
Bona fide gift
|
Direct | 2,000 Reduced 0.52% |
-
|
May 29
2025 |
|
BAND
|
David A. Morken
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 4,999 Reduced 41.79% |
$72,335
$14.47 p/Share
|
May 29
2025 |
|
CNMD
|
Charles Farkas
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 966 Reduced 5.57% |
$55,728
$57.69 p/Share
|
May 29
2025 |
|
CNMD
|
Charles Farkas
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,000 Added 5.45% |
$55,700
$55.7 p/Share
|
May 29
2025 |
|
REYN
|
Chris Mayrhofer
VP, Controller & CAO |
BUY
Open market or private purchase
|
Indirect | 18,217 Added 0.0% |
$403,324
$22.14 p/Share
|
May 29
2025 |
|
CQP
|
Ellis L Mccain
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 13.33% |
-
|
May 29
2025 |
|
LION
|
Liberty 77 Capital L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,454,045 Added 0.0% |
$22,693,075
$6.57 p/Share
|
May 29
2025 |
|
ELY
|
Laura Jean Flanagan
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 8,096 Added 13.9% |
-
|
May 29
2025 |
|
STKL
|
Diego Reynoso
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,072 Added 29.49% |
-
|
May 29
2025 |
|
STX
|
Gianluca Romano
EVP & CFO |
SELL
Open market or private sale
|
Direct | 25,018 Reduced 39.65% |
$2,936,112
$117.36 p/Share
|
May 29
2025 |
|
MLSS
|
S.R.L. Bp4
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 3,361 Reduced 0.03% |
$3,226
$0.96 p/Share
|
May 29
2025 |
|
INNV
|
Richard C Zoretic
Director |
BUY
Open market or private purchase
|
Direct | 14,265 Added 19.2% |
$57,630
$4.04 p/Share
|
May 29
2025 |
|
TRV
|
David Donnay Rowland
EVP & Co-Chief Invest. Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 12,069 Added 33.65% |
$1,566,797
$129.82 p/Share
|
May 29
2025 |
|
TRV
|
David Donnay Rowland
EVP & Co-Chief Invest. Officer |
SELL
Open market or private sale
|
Direct | 12,069 Reduced 50.71% |
$3,307,026
$274.01 p/Share
|
May 29
2025 |
|
STKL
|
Rebecca Fisher
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,072 Added 12.85% |
-
|
May 29
2025 |
|
CRSP
|
Naimish Patel
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,932 Reduced 39.32% |
$141,316
$35.94 p/Share
|
May 29
2025 |
|
PFGC
|
Erika T Davis |
SELL
Open market or private sale
|
Direct | 8,200 Reduced 14.93% |
$736,114
$89.77 p/Share
|
May 29
2025 |
|
PJT
|
Kievdi Don Cornwell |
SELL
Open market or private sale
|
Direct | 9,597 Reduced 33.27% |
$1,449,914
$151.08 p/Share
|
May 29
2025 |
|
PFGC
|
A Brent King |
SELL
Open market or private sale
|
Direct | 12,866 Reduced 17.43% |
$1,158,197
$90.02 p/Share
|
May 29
2025 |
|
PFGC
|
A Brent King |
BUY
Exercise of conversion of derivative security
|
Direct | 7,866 Added 9.63% |
$226,540
$28.8 p/Share
|
May 29
2025 |
|
EVC
|
Paul A Zevnik |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 26.64% |
-
|
May 29
2025 |
|
EVC
|
Gilbert R Vasquez |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 7.28% |
-
|
May 29
2025 |
|
EVC
|
Fehmi Alexander Zeko |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 20.3% |
-
|
May 29
2025 |
|
EVC
|
Martha Elena Diaz |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 18.22% |
-
|
May 29
2025 |
|
EVC
|
Brad Bender |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 29.47% |
-
|
May 29
2025 |
|
EVC
|
Lara Sweet |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 30.18% |
-
|
May 29
2025 |
|
EVC
|
Thomas Strickler |
BUY
Grant, award, or other acquisition
|
Direct | 74,879 Added 28.35% |
-
|
May 29
2025 |
|
STKL
|
Mahes Wickramasinghe
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,072 Added 30.76% |
-
|
May 29
2025 |
|
TRV
|
Alan D Schnitzer
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 162,927 Added 27.7% |
$22,948,267
$140.85 p/Share
|
May 29
2025 |
|
TRV
|
Alan D Schnitzer
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 35,456 Reduced 11.91% |
$9,704,661
$273.71 p/Share
|
May 29
2025 |
|
TRV
|
Alan D Schnitzer
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 127,471 Reduced 29.98% |
$34,988,240
$274.48 p/Share
|
May 29
2025 |
|
SARO
|
Gic Private LTD |
SELL
Open market or private sale
|
Indirect | 828,729 Reduced 0.0% |
$22,624,301
$27.3 p/Share
|
May 29
2025 |
|
STKL
|
Albert D. Bolles
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,072 Added 8.14% |
-
|
May 29
2025 |
|
STKL
|
Leslie Starr Keating
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,072 Added 13.63% |
-
|
May 29
2025 |
|
TRV
|
Mojgan M Lefebvre
EVP & Chief Tech & Ops Officer |
SELL
Open market or private sale
|
Direct | 6,148 Reduced 100.0% |
$1,682,769
$273.71 p/Share
|
May 29
2025 |
|
STKL
|
Richard Dean Hollis
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,072 Added 3.37% |
-
|
May 29
2025 |
|
CORZ
|
Elizabeth Crain |
BUY
Grant, award, or other acquisition
|
Direct | 46,773 Added 50.0% |
-
|
May 29
2025 |
|
CCO
|
John D. Dionne |
BUY
Grant, award, or other acquisition
|
Direct | 6,172 Added 0.9% |
$6,604
$1.07 p/Share
|
May 29
2025 |